3,3′-diindolylmethane attenuates colonic inflammation and tumorigenesis in mice

Abstract

These results suggest that DIM-mediated antiinflammatory action at colorectal sites may be therapeutic in the setting of inflammatory bowel disease and colitis-associated colon cancer.